What should you know about Illumina next-generation sequencing?

A laboratory extracts DNA or RNA from a sample such as blood, saliva, an embryo, or tumour tissue. The material is prepared and placed on a sequencing system. The instrument detects the order of genetic building blocks as copied fragments are read, then software compares the result with a reference sequence or examines selected changes. The test may look at a defined group of genes or a broader set, depending on the clinical question.

A result can be reassuring, actionable, uncertain, or limited by the sample. A finding does not automatically diagnose cancer or predict what will happen to one person. In tumour testing, results may help clinicians consider treatment options; in inherited testing, the meaning may involve relatives and genetic counselling.

Ask what sample is needed, which genes or regions will be examined, and whether the test is looking for inherited changes or changes found only in a tumour. Check how results will be reported, who will explain uncertain findings, and whether a follow-up test is needed. Tell the team about family history and previous genetic results. Do not change treatment, fertility plans, or pregnancy decisions from a sequencing result without a qualified clinician explaining its meaning.

Sequencing itself is a laboratory process, so it does not usually create a physical emergency. Contact the requesting clinician if the sample cannot be collected, a report is unclear, or you receive a result that raises immediate concerns about treatment or inherited risk. Seek urgent medical care for symptoms from the underlying condition, such as severe breathing difficulty, heavy bleeding, or sudden confusion, rather than waiting for genetic results.

Ask what the test can and cannot detect, whether it covers inherited risk, how a variant is classified, whether relatives may need advice, and when results are expected. Ask who provides counselling and what happens if the sample is inadequate.